0001237899-11-000037.txt : 20110705 0001237899-11-000037.hdr.sgml : 20110704 20110705161514 ACCESSION NUMBER: 0001237899-11-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110701 FILED AS OF DATE: 20110705 DATE AS OF CHANGE: 20110705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSTEIN JOSEPH L CENTRAL INDEX KEY: 0001225474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 11949722 MAIL ADDRESS: STREET 1: DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS STREET 2: 5323 HARRY HINES BLVD CITY: DALLAS STATE: TX ZIP: 75390 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2011-07-01 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225474 GOLDSTEIN JOSEPH L 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2011-07-01 4 M 0 800 28.81 A 800 D Common Stock 2011-07-01 4 S 0 800 55.91 D 0 D Common Stock 2011-07-01 4 M 0 9200 28.81 A 9200 D Common Stock 2011-07-01 4 S 0 9200 56.4 D 0 D Non-Qualified Stock Option (right to buy) 28.81 2011-07-01 4 M 0 800 D 2012-01-01 Common Stock 800 9200 D Non-Qualified Stock Option (right to buy) 28.81 2011-07-01 4 M 0 9200 D 2012-01-01 Common Stock 9200 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The reporting person sold 800 shares of Company stock on July 1, 2011 at prices ranging from $55.87 to $55.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2011 at each separate price. The reporting person sold 9,200 shares of Company stock on July 1, 2011 at prices ranging from $56.10 to $56.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on July 1, 2011 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is not applicable in this case. Goldstein, Joseph 2011-07-03